Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy-Reference-Cited by-同舟云学术

Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy

Published:2024-06-24 Issue:26 Volume:18 Page:17119-17134
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

You Yuchan¹,Zhu Luwen¹,Song Yanling¹,Hu Jiahao¹,Chen Minjiang²,Zhang Jucong¹,Xu Xinyi¹,Huang Xiajie¹,Wu Xiaochuan¹^ORCID,Lu Jingyi¹,Tong Xiangmin³,Ji Jian-Song²^ORCID,Du Yong-Zhong¹⁴^ORCID

Affiliation:

1. College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, P. R. China

2. Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, 289 Kuocang Road, Lishui 323000, P. R. China

3. Department of Hematology, the Affiliated Hangzhou First People’s Hospital, Westlake University School of Medicine, Hangzhou 310006, P. R. China

4. Innovation Center of Transformational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua 321299, P. R. China

Funder

National Key Research and Development Program of China

Natural Science Foundation of Zhejiang Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c03767

Reference49 articles.

1. Developing TRAIL/TRAIL death receptor-based cancer therapies

2. Death receptor 5 rises to the occasion

3. Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells

4. A novel domain within the 55 kd TNF receptor signals cell death

5. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy